BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 26148903)

  • 1. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S; Vanhecke D; Trendelenburg M
    Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages.
    Thanei S; Trendelenburg M
    J Leukoc Biol; 2017 Feb; 101(2):481-491. PubMed ID: 27630215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y; Yang XW; Song Y; Yu F; Zhao MH
    Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
    Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against C1q in patients with systemic lupus erythematosus.
    Trendelenburg M
    Springer Semin Immunopathol; 2005 Nov; 27(3):276-85. PubMed ID: 16189648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways.
    Ceribelli A; Andreoli L; Cavazzana I; Franceschini F; Radice A; Rimoldi L; Sinico RA; Carlsson M; Wieslander J; Tincani A
    Ann N Y Acad Sci; 2009 Sep; 1173():427-34. PubMed ID: 19758182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages.
    Thanei S; Trendelenburg M
    J Immunol; 2016 Mar; 196(5):2063-74. PubMed ID: 26829984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus.
    Frémeaux-Bacchi V; Weiss L; Demouchy C; Blouin J; Kazatchkine MD
    Lupus; 1996 Jun; 5(3):216-20. PubMed ID: 8803893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
    Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus.
    Seelen MA; Trouw LA; van der Hoorn JW; Fallaux-van den Houten FC; Huizinga TW; Daha MR; Roos A
    Clin Exp Immunol; 2003 Nov; 134(2):335-43. PubMed ID: 14616796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
    Gunnarsson I; Rönnelid J; Huang YH; Rogberg S; Nilsson B; Lundberg I; Klareskog L
    Br J Rheumatol; 1997 Jan; 36(1):32-7. PubMed ID: 9117171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.
    Siegert C; Daha M; Westedt ML; van der Voort E; Breedveld F
    J Rheumatol; 1991 Feb; 18(2):230-4. PubMed ID: 2023216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A; Pipi E; Soufleros K
    Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.